Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-05-31FDA Approved: GLIMEPIRIDE — Supplemental Application (Accord Healthcare Inc)
The FDA approved a supplemental application for glimepiride by Accord Healthcare Inc, authorizing changes to the approved product.
-
FDA approval · 2019-05-31FDA Approved: GLIMEPIRIDE — Supplemental Application (Carlsbad Technology, Inc.)
FDA approved a supplemental application for glimepiride from Carlsbad Technology, Inc., granting approval to market a generic form of the di…
-
FDA approval · 2019-05-31FDA Approved: GLIMEPIRIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for glimepiride from Dr. Reddy's Laboratories Limited. Glimepiride is a generic drug used to treat t…
-
FDA approval · 2019-05-31FDA Approved: GLIMEPIRIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Glimepiride from Rising Pharma Holdings, Inc., signaling regulatory clearance for a change t…
-
CLINICAL_TRIALS research · 2019-05-31Clinical Trial Update: Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis [Phase 4]
Phase 4 clinical trial evaluating the use of CCTA and MRI to detect unrecognized myocardial scar in asymptomatic patients with type 2 diabet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-05-31Clinical Trial Update: A 12/24-weeks, Open, Multi-centre, Phase IV Study on Safety and Efficacy of 2mg Exenatide Once Weekly (Bydureon) in T2DM Patients. [Phase 4]
Phase IV trial update assessing safety and efficacy of 2 mg exenatide weekly (Bydureon) in type 2 diabetes mellitus; study completed with po…
-
CLINICAL_TRIALS trial_result · 2019-05-24Clinical Trial Update: Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 Diabetes [Phase 2]
Phase 2 trial evaluating the effects and safety of ZGN-1061 in overweight/obese individuals with type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-23Clinical Trial Update: A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes Mellitus [Phase 2]
Phase 2 trial update of GX-G6 in patients with uncontrolled type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2019-05-22Clinical Trial Update: Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes [NA]
A completed clinical trial evaluating the impact of sitagliptin on cardiovascular exercise performance in adults with type 2 diabetes and ca…
-
CLINICAL_TRIALS trial_result · 2019-05-22Clinical Trial Update: Efficacy of Black Seed Oil in Patients With Type 2 Diabetes Mellitus [Phase 2]
Phase 2 trial evaluating the efficacy of black seed oil in patients with type 2 diabetes; current status and results are not provided in the…
-
FDA approval · 2019-05-21FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Welchol (colesevelam hydrochloride) from Cosette Pharmaceuticals, Inc., resulting in changes to …
-
FDA approval · 2019-05-21FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA has approved Cosette Pharmaceuticals' supplemental application for Welchol (colesevelam hydrochloride). This action constitutes an a…
-
CLINICAL_TRIALS trial_result · 2019-05-20Clinical Trial Update: Type 2 Diabetes and Exercise Function in Single Leg Exercises [NA]
A completed clinical trial investigating exercise function in individuals with Type 2 Diabetes; results have been posted.
-
CLINICAL_TRIALS trial_result · 2019-05-14Clinical Trial Update: Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients [NA]
A completed clinical trial evaluating the combination of incretin-based therapy with canagliflozin for glycemic control in type 2 diabetes a…
-
CLINICAL_TRIALS trial_result · 2019-05-13Clinical Trial Update: Effects of Glutamine on GLP-1 and Insulin Secretion in Man [NA]
A completed clinical trial investigating how glutamine affects GLP-1 and insulin secretion in individuals with Type 2 diabetes; results post…
-
CLINICAL_TRIALS trial_result · 2019-05-10Clinical Trial Update: Long-term Daily Use of Trazenta® Tablets in Patients With Type 2 Diabetes Mellitus
A completed clinical trial evaluating long-term daily use of Trazenta tablets in patients with type 2 diabetes; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-05-10Clinical Trial Update: BM-MNCs and UC-MSCs Infusion for Type 2 Diabetes Mellitus Patients [Phase 1, Phase 2]
Phase 1/2 clinical trial investigating bone marrow mononuclear cells (BM-MNCs) and umbilical cord-derived mesenchymal stem cells (UC-MSCs) i…
-
CLINICAL_TRIALS trial_result · 2019-05-10Clinical Trial Update: Treatment Preference for Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Daily DPP-4 Inhibitors in Participants With Type 2 Diabetes Mellitus [Phase 4]
A Phase 4 clinical trial comparing weekly versus daily DPP-4 inhibitors in adults with Type 2 diabetes mellitus has completed and results we…
-
FDA approval · 2019-05-09FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for LANTUS SOLOSTAR (insulin glargine) from Sanofi-aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2019-05-09Clinical Trial Update: A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes [Phase 2]
Phase 2 clinical trial update for BMS-986036 in obese adults with type 2 diabetes has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-05-09Clinical Trial Update: Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus
Clinical trial update for alogliptin tablets under special surveillance in mild type 2 diabetes mellitus; study completed with results poste…
-
CLINICAL_TRIALS trial_result · 2019-05-08Clinical Trial Update: Ursodiol on Insulin Sensitivity, Gastric Emptying and Body Weight With Type 2 Diabetes on Metformin [Phase 2]
Phase 2 clinical trial examining the effects of Ursodiol on insulin sensitivity, gastric emptying, and body weight in adults with Type 2 Dia…
-
FDA approval · 2019-05-06FDA Approved: COLESEVELAM HYDROCHLORIDE — Original Application (Ascend Laboratories, LLC)
FDA approved an original application for Colesevelam hydrochloride (generic) from Ascend Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2019-05-06Clinical Trial Update: Real World Glycemic Effectiveness of Linagliptin
A completed real-world study evaluating the glycemic effectiveness of linagliptin in type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2019-05-02Clinical Trial Update: Vildagliptin Versus Dapagliflozin on Glucagon [Phase 4]
A Phase 4 trial comparing vildagliptin versus dapagliflozin assessing effects on glucagon in type 2 diabetes completed with results posted i…